Biologics

The global spine biologics market will likely grow at a compound annual growth rate of 4.5 percent between 2018 and 2023, based on a Market.biz report, according to Business News.

Bone Biologics, based in Burlington, Mass., is a publicly traded company focused on orthobiologic solutions.

Luga Podesta, MD, is a sports medicine and regenerative orthopedic specialist at Bluetail Medical Group in Naples, Fla. He was the lead author in a 2013 study in The American Journal of Sports Medicine which demonstrated that platelet-rich plasma can…

The global orthobiologics market is expected to grow from $4.66 billion in 2017 to reach $8.06 billion by 2023, increasing at a 5.7 percent compound annual growth rate, according to a Market.Biz report.

U.K.-based Tissue Regenix Group inked a deal with Premier for TRX's flagship product DermaPure to maintain access to 3,900 hospitals and more than 150,000 healthcare providers in the U.S., according to proactiveinvestors UK.

Biologica Technologies will exhibit clinical data for its ProteiOS growth factor at the American Association of Neurological Surgeons Annual Scientific Meeting in New Orleans.

Medtronic received FDA clearance for a new indication with its Infuse Bone Graft.

The phase I/II U.S. clinical trial testing DiscGenics' IDCT for treating degenerative disc disease is underway.

Datum Orthobiologics was recently founded to provide orthopedic ossification, bone formation and tissue regeneration solutions.

A Siberian tiger at the Szeged Zoo in Hungary received Lipogems stem cell therapy for a hip joint problem April 18, euronews.com reports.